The Week Ahead - Don't Look Up

Everything you need to know about the Solar Eclipse

Author

HY Harry
April 07, 2024

Sponsored by

Welcome Back! Let’s get into it.

The week ahead of us 🔍

2Q24 Earnings Season kicks off this week, with the Banks starting to report later in the week.

  • Tuesday: Tilray

  • Wednesday: Delta, Rent the Runway

  • Thursday: Constellation Brands, Fastenal

  • Friday: JP Morgan, Wells Fargo, Progressive, BlackRock, Citi, State Street

The main story 📰

On Monday April 8th, 2024, a Solar Eclipse will cross 15 U.S. states: Even though the Sun is 400x wider than the Moon, the Moon’s proximity to us will result in the Moon covering the Sun briefly on Monday. Around 32mm will have the moon completely blocking the sun, however another 150mm people live within a 200 mile radius of the path and will get a glimpse. This will start at 11:08 PDT and last anywhere from 1 - 4minutes long. However, not every big city is going to get a good glimpse. NYC for example, as you can see below is well out of the total eclipse path.

However, please note you need to be wearing specific glasses that filter out harmful radiation coming from the sun. These need to have ISO certification on them to effectively work. Once in totality (aka total eclipse), you can take the glasses off, but so long as there’s light around the edges, you NEED to have your glasses on.

This will be the only North American coast-to-coast eclipse until 2045! So if you’re going to check it out, Monday is your chance!

Noteworthy insider trade 🚨

The Dave and Buster’s ($PLAY) Chair sold 75,000 shares at a price of $65.71 (a $4.9mm sale). He now holds 152,000 shares post this sale.

A Message From Our Sponsor

How did @TheArbFather make $10,000+ profit in February?

His secret sauce: Arbitrage betting.

Instead of getting bettings tips from slick-talking handicappers, TheArbFather bets on both sides of an outcome to guarantee a risk-free return. An example of this is betting on a game total to be over 224.5 AND under 224.5.

This might sound too good to be true, but the reason this can happen is sportsbooks set their lines for games independently. Sometimes, they make mistakes and there are situations where FanDuel’s odds are different from DraftKings’ odds.

Unless you are a PhD-wielding, Python-coding, Excel-Wizard… finding arbitrage opportunities consistently has been out of reach. Until now…

OddsJam scans millions of odds every second and finds these need-in-a-haystack opportunities that you can bet on to secure a risk-free profit.

Headlines and Articles 

Transactions and M&A 💭 

Daseke (NAS: DSSKE), a provider of transportation and logistics solutions focused exclusively on flatbed and specialized freight in North America, was acquired for $1.1B by TFI International (TSE: TTFII). J.P. Morgan Advised on the sale.

Kinnate Biopharma, a clinical-stage precision oncology company focused on discovery, design, and development of small molecule kinase inhibitors for difficult to treat, gnomically defined cancers, was acquired for $122.21M for Xoma (NAS: XOMA). Lazard, Leerink Partners, and Westwicke advised on the sale.

ProfoundBio, a developer of novel targeted therapeutics intended for patients with cancer, was acquired for $1.8B by Genmab (CSE: GMAB). Bank of America and Morgan Stanley advised on the sale.

Rag & Bone, manufacturer of clothing and shoes, was acquired for $114.2M by WHP Global and Guess (NYS: GES). Solomon Partners advised on the sale.

ShockWave Medical (NAS: SWAV), a medical device company focused on developing and commercializing novel technologies, reached a definitive agreement to be acquired for $13.1B by Johnson & Johnson (NYS: JNJ).

BankCard USA Merchant Services, a provider of credit card processing services, was acquired for $100.0M by Quisitive Technology Solutions (TSX: QUIS). Elmcore Group and William Blair & Company advised on the sale.

Transactions Private Placements 💭

Celestial AI, developer of a data center and AI computing platform, raised $175.0M of Series C venture funding led by US Innovative Technology Fund at a pre-money valuation of $1.0B.

MN8 Energy, a renewable energy company, received $325.0M of development capital from Mercuria Energy Trading and Ridgewood Infrastructure.

Mirador Therapeutics, an operator of a biotechnology company intended to offer medicine for immune-mediated inflammatory and fibrotic diseases, raised $400.0M of venture funding led by ARCH Venture Partners.

Avenzo, an operator of a clinical-stage oncology platform, raised $223.35M through a combination of Series A and Series A-1 venture funding led by Deep Track Capital, Sands Capital, and Sofinnova Investments at a pre-money valuation of $96.65M.

Aerospike, a developer of a database platform designed to help industries in scaling data, raised $114.0M of Series E venture funding led by Sumeru Equity Partners.

Pigment, a developer of a business planning platform intended to help clients intuitively and intelligently built and adapt strategic plans, raised $145.0M of Series D venture funding led by ICONIQ Growth.

Noteworthy Chart 🧭

---------------

Best Video ⌚️

Tesla will unveil Robotaxis on August 8th, 2024:

Odds of the Week 🍒 

How many times will the Fed cut this year? Traders on Kalshi think it could be only twice.

Meme Cleanser 😆 

In Other News

  • Check out some Wall Street and Finance Merch Here

  • Our Newsletter is completely free! To support our content, make sure you check out the placements of our Newsletter Sponsors